AAAAAA
Results:
1-21
|
Results: 21
Authors:
Tokay, S
Direskeneli, H
Yurdakul, S
Akoglu, T
Citation: S. Tokay et al., Anticardiolipin antibodies in Behcet's disease: a reassessment, RHEUMATOLOG, 40(2), 2001, pp. 192-195
Authors:
Eksioglu-Demiralp, E
Direskeneli, H
Kibaroglu, A
Yavuz, S
Ergun, T
Akoglu, T
Citation: E. Eksioglu-demiralp et al., Neutrophil activation in Behcet's disease, CLIN EXP RH, 19(5), 2001, pp. S19-S24
Authors:
Ergun, T
Ince, U
Eksioglu-Demiralp, E
Direskeneli, H
Gurbuz, O
Gurses, L
Aker, F
Akoglu, T
Citation: T. Ergun et al., HSP 60 expression in mucocutaneous lesions of Behcet's disease, J AM ACAD D, 45(6), 2001, pp. 904-909
Authors:
Saruhan-Direskeneli, G
Celet, B
Eksioglu-Demiralp, E
Direskeneli, H
Citation: G. Saruhan-direskeneli et al., Human HSP 60 peptide responsive T cell lines are similarly present in bothBehcet's disease patients and healthy controls, IMMUNOL LET, 79(3), 2001, pp. 203-208
Authors:
Direskeneli, H
Citation: H. Direskeneli, Behet's disease: infectious aetiology, new autoantigens, and HLA-B51, ANN RHEUM D, 60(11), 2001, pp. 996-1002
Authors:
Ekenel, M
Yavuz, S
Karti, S
Direskeneli, H
Akoglu, T
Citation: M. Ekenel et al., Remitting seronegative symmetrical synovitis with pitting oedema associated with chronic lymphocytic leukaemia, CLIN RHEUMA, 19(3), 2000, pp. 247-248
Authors:
Mantas, C
Direskeneli, H
Oz, D
Yavuz, S
Akoglu, T
Citation: C. Mantas et al., IL-8 producing cells in patients with Behcet's disease, CLIN EXP RH, 18(2), 2000, pp. 249-251
Authors:
Direskeneli, H
Eksioglu-Demiralp, E
Yavuz, S
Ergun, T
Shinnick, T
Lehner, T
Akoglu, T
Citation: H. Direskeneli et al., T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behcet's disease, J RHEUMATOL, 27(3), 2000, pp. 708-713
Authors:
D'Cruz, D
Keser, G
Khamashta, MA
Direskeneli, H
Targoff, IN
Miller, F
Hughes, GRV
Citation: D. D'Cruz et al., Antiendothelial cell antibodies in inflammatory myopathies: Distribution among clinical and serologic groups and association with interstitial lung disease, J RHEUMATOL, 27(1), 2000, pp. 161-164
Authors:
Basaran, Y
Degertekin, M
Direskeneli, H
Yakut, C
Citation: Y. Basaran et al., Cardiac thrombosis in a patient with Behcet's disease: Two years follow-up, INT J CAR I, 16(5), 2000, pp. 377-382
Authors:
Kurhan-Yavuz, S
Direskeneli, H
Bozkurt, N
Ozyazgan, Y
Bavbek, T
Kazokoglu, H
Eksioglu-Demiralp, E
Wildner, G
Diedrichs-Mohring, M
Akoglu, T
Citation: S. Kurhan-yavuz et al., Anti-MHC autoimmunity in Behcet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis, CLIN EXP IM, 120(1), 2000, pp. 162-166
Authors:
Hamuryudan, V
Fresko, I
Direskeneli, H
Tenant, MJ
Yurdakul, S
Akoglu, T
Yazici, H
Citation: V. Hamuryudan et al., Evaluation of the Turkish translation of a disease activity form for Behcet's syndrome, RHEUMATOLOG, 38(8), 1999, pp. 734-736
Authors:
Direskeneli, H
Ozdogan, H
Korkmaz, C
Akoglu, T
Yazici, H
Citation: H. Direskeneli et al., Serum soluble intercellular adhesion molecule 1 and interleukin 8 levels in familial Mediterranean fever, J RHEUMATOL, 26(9), 1999, pp. 1983-1986
Authors:
Eksioglu-Demiralp, E
Kibaroglu, A
Direskeneli, H
Yavuz, S
Karsli, F
Yurdakul, S
Yazici, H
Akoglu, T
Citation: E. Eksioglu-demiralp et al., Phenotypic characteristics of B cells in Behcet's disease: Increased activity in B cell subsets, J RHEUMATOL, 26(4), 1999, pp. 826-832
Authors:
Eksioglu-Demiralp, E
Direskeneli, H
Akoglu, T
Citation: E. Eksioglu-demiralp et al., Levels of serum transforming growth factor-beta 1 do not increase in Behcet's disease, in contrast to rheumatoid arthritis, J RHEUMATOL, 26(4), 1999, pp. 1010-1011
Authors:
Mantas, C
Direskeneli, H
Eksioglu-Demiralp, E
Akoglu, T
Citation: C. Mantas et al., Serum levels of Th2 cytokines IL-4 and IL-10 in Behcet's disease, J RHEUMATOL, 26(2), 1999, pp. 510-512
Authors:
D'Cruz, D
Direskeneli, H
Khamashta, M
Hughes, GRV
Citation: D. D'Cruz et al., Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: Potential markers for disease activity, J RHEUMATOL, 26(1), 1999, pp. 103-109
Authors:
Eksioglu-Demiralp, E
Direskeneli, H
Ergun, T
Fresko, I
Akoglu, T
Citation: E. Eksioglu-demiralp et al., Increased CD4(+)CD16(+) and CD4(+)CD56(+) T cell subsets in Behcet's disease, RHEUM INTL, 19(1-2), 1999, pp. 23-26
Authors:
Direskeneli, H
Eksioglu-Demiralp, E
Kibaroglu, A
Yavuz, S
Ergun, T
Akoglu, T
Citation: H. Direskeneli et al., Oligoclonal T cell expansions in patients with Behcet's disease, CLIN EXP IM, 117(1), 1999, pp. 166-170
Authors:
D'Cruz, DP
Keser, G
Direskeneli, H
Khamashta, MA
Hughes, GRV
Citation: Dp. D'Cruz et al., Anti-endothelial cell antibodies in systemic vasculitis and systemic lupuserythematosus (SLE): effects of heat inactivation on binding and specificity, CLIN EXP IM, 115(3), 1999, pp. 567-570
Authors:
Budak-Alpdogan, T
Demircay, Z
Alpdogan, O
Direskeneli, H
Ergun, T
Ozturk, A
Gunay, A
Yavuz, S
Uskent, N
Akoglu, T
Citation: T. Budak-alpdogan et al., Skin hyperreactivity of Behcet's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disorders, BR J RHEUM, 37(11), 1998, pp. 1148-1151
Risultati:
1-21
|